about
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genesLost in translation: returning germline genetic results in genome-scale cancer researchPersonalising pancreas cancer treatment: When tissue is the issue.Gastrointestinal perforation in metastatic colorectal cancer patients with peritoneal metastases receiving bevacizumabPathogenic PALB2 mutation in metastatic pancreatic adenocarcinoma and neuroendocrine tumour: A case report.Whole genomes redefine the mutational landscape of pancreatic cancer.ICECREAM: randomised phase II study of cetuximab alone or in combination with irinotecan in patients with metastatic colorectal cancer with either KRAS, NRAS, BRAF and PI3KCA wild type, or G13D mutated tumours.Adjuvant chemotherapy in elderly patients with pancreatic cancer.Clinical and molecular characterization of HER2 amplified-pancreatic cancer.Precision Medicine for Advanced Pancreas Cancer: The Individualized Molecular Pancreatic Cancer Therapy (IMPaCT) Trial.Predictive and prognostic biomarkers for neoadjuvant chemoradiotherapy in locally advanced rectal cancer.Emerging Drug Target In Pancreatic Cancer: Placing Sirtuin 1 on the Canvas.Genomic analyses identify molecular subtypes of pancreatic cancer.Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of vater.Response to Cetuximab With or Without Irinotecan in Patients With Refractory Metastatic Colorectal Cancer Harboring the KRAS G13D Mutation: Australasian Gastro-Intestinal Trials Group ICECREAM Study.Risk of arterial thromboembolic events in patients with advanced colorectal cancer receiving bevacizumab.Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasis.Hypermutation In Pancreatic Cancer.Tailored first-line and second-line CDK4-targeting treatment combinations in mouse models of pancreatic cancer.Current challenges in optimizing systemic therapy for patients with pancreatic cancer: expert perspectives from the Australasian Gastrointestinal Trials Group (AGITG) with invited international faculty.Corrigendum: Whole-genome landscape of pancreatic neuroendocrine tumours.Whole-genome landscape of pancreatic neuroendocrine tumours.Chemotherapy and radiotherapy for advanced pancreatic cancer.Clinical and pathologic features of familial pancreatic cancerPrevalence and distribution of human papillomavirus type-16 DNA in pelvic lymph nodes of patients with cervical cancer and in women with no history of cervical abnormalityMetastatic pancreatic ductal adenocarcinoma: diagnosis and treatment with a view to the future
P50
Q24595981-8089EEAC-A5C7-4DB0-9B5F-B4F0005AD9B2Q33613050-06D47A5C-E7D5-4165-98F4-B3644851101EQ33801384-DE71111F-CAF5-428F-B01A-4807B03AE707Q35567689-D927133B-FB10-4439-A6CE-74FDE76A9A2FQ35803533-5C47C6A7-4C1A-4515-AC18-A85D92F23B1DQ35911034-C997AD47-7EF0-42BC-8B3A-8EE74811F527Q36035723-4D021D89-5D84-4571-ACA3-37E614CC3F3DQ37507381-644EC423-609B-4D0A-AB4F-BB6D9CE1A717Q37690146-AFBBA389-C2CD-4CCD-83A2-FE72F6467B01Q38386761-77E2E4A7-CCC4-495F-85DE-3D6843E4D40FQ38511709-A9A5CED7-79FE-484E-88F0-C3321DEDB17DQ38568551-7F337E66-D563-4BCB-90F0-5A17AA2609CEQ38791499-4B152F3C-F50D-4C42-A43A-3811F28767D9Q39461783-73AA4E4D-20EF-4DF2-9C58-1DD58E58ACF8Q39821902-10956670-3871-4711-ACCC-E8216B701F04Q44454368-7D297483-C945-4EF7-A126-3E258BE36B94Q45987365-033DD567-799A-490D-A5C2-39A8D96D9722Q46267270-0E84D069-E815-413B-BB3F-14D12659594CQ47590783-7D5443A1-7411-4E78-A701-DA28DE543114Q48221094-6C287B1A-D7A8-4BD2-AE3A-6EACC1E4713BQ49720507-276CACD2-079C-46B9-AB4E-5C31FB18DF7BQ51137102-AB4F5F7F-602B-48DA-B6F8-6F17DC4AD69AQ52647259-FEB1D553-A665-4479-8778-A09CF0F9FC06Q57422192-987C8771-49BA-4D31-914B-D7993B45AA8CQ57422237-D83D49D7-55AE-4576-8211-A32B7C54067FQ89091192-1E5FE886-F561-4F96-90AD-A00E1E7C6956
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Lorraine A Chantrill
@ast
Lorraine A Chantrill
@en
Lorraine A Chantrill
@es
Lorraine A Chantrill
@nl
Lorraine A Chantrill
@sl
type
label
Lorraine A Chantrill
@ast
Lorraine A Chantrill
@en
Lorraine A Chantrill
@es
Lorraine A Chantrill
@nl
Lorraine A Chantrill
@sl
prefLabel
Lorraine A Chantrill
@ast
Lorraine A Chantrill
@en
Lorraine A Chantrill
@es
Lorraine A Chantrill
@nl
Lorraine A Chantrill
@sl
P106
P31
P496
0000-0002-5790-0208